Pathway ID | hsa05206 |
Pathway Term | MicroRNAs in cancer |
Pathway Source | KEGG |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
10018 |
O43521 |
chr2: 111,119,378-111,168,447 |
CDK6 |
cyclin-dependent kinase 6 |
1021 |
Q00534 |
chr7: 92,604,921-92,836,594 |
SPRY2 |
sprouty RTK signaling antagonist 2 |
10253 |
O43597 |
chr13: 80,335,976-80,340,951 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 |
P38936 |
chr6: 36,676,460-36,687,339 |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
1027 |
P46527 |
chr12: 12,715,058-12,722,371 |
RASSF1 |
Ras association (RalGDS/AF-6) domain family member 1 |
11186 |
Q9NS23 |
chr3: 50,329,782-50,340,980 |
CDCA5 |
cell division cycle associated 5 |
113130 |
Q96FF9 |
chr11: 65,066,300-65,084,164 |
CREBBP |
CREB binding protein |
1387 |
Q92793 |
chr16: 3,725,054-3,880,726 |
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
1399 |
P46109 |
chr22: 20,917,426-20,953,749 |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
1545 |
Q16678 |
chr2: 38,066,973-38,109,902 |
DNMT1 |
DNA (cytosine-5-)-methyltransferase 1 |
1786 |
P26358 |
chr19: 10,133,345-10,231,286 |
DNMT3B |
DNA (cytosine-5-)-methyltransferase 3 beta |
1789 |
Q9UBC3 |
chr20: 32,762,385-32,809,356 |
E2F1 |
E2F transcription factor 1 |
1869 |
Q01094 |
chr20: 33,675,683-33,686,404 |
E2F2 |
E2F transcription factor 2 |
1870 |
Q14209 |
chr1: 23,506,430-23,531,220 |
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
EP300 |
E1A binding protein p300 |
2033 |
Q09472 |
chr22: 41,091,786-41,180,079 |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
2064 |
P04626 |
chr17: 39,687,914-39,730,426 |
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
2065 |
P21860 |
chr12: 56,079,857-56,103,505 |
EZH2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
2146 |
Q15910 |
chr7: 148,807,383-148,884,321 |
DICER1 |
dicer 1, ribonuclease type III |
23405 |
Q9UPY3 |
chr14: 95,086,228-95,158,010 |
ZFPM2 |
zinc finger protein, FOG family member 2 |
23414 |
Q8WW38 |
chr8: 104,590,733-105,804,532 |
FOXP1 |
forkhead box P1 |
27086 |
Q9H334 |
chr3: 70,954,693-71,583,989 |
PDCD4 |
programmed cell death 4 (neoplastic transformation inhibitor) |
27250 |
Q53EL6 |
chr10: 110,871,795-110,900,006 |
GLS |
glutaminase |
2744 |
O94925 |
chr2: 190,880,827-190,965,552 |
GRB2 |
growth factor receptor bound protein 2 |
2885 |
P62993 |
chr17: 75,318,076-75,405,709 |
HDAC1 |
histone deacetylase 1 |
3065 |
Q13547 |
chr1: 32,292,086-32,333,635 |
HMOX1 |
heme oxygenase 1 |
3162 |
P09601 |
chr22: 35,380,361-35,394,214 |
HOXD10 |
homeobox D10 |
3236 |
P28358 |
chr2: 176,108,790-176,119,942 |
APC |
adenomatous polyposis coli |
324 |
P25054 |
chr5: 112,707,498-112,846,239 |
TNC |
tenascin C |
3371 |
P24821 |
chr9: 115,019,578-115,118,257 |
IRS1 |
insulin receptor substrate 1 |
3667 |
P35568 |
chr2: 226,731,317-226,799,759 |
ITGA5 |
integrin subunit alpha 5 |
3678 |
P08648 |
chr12: 54,395,261-54,419,460 |
ITGB3 |
integrin subunit beta 3 |
3690 |
P05106 |
chr17: 47,253,846-47,311,816 |
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
3845 |
P01116 |
chr12: 25,204,789-25,250,936 |
RHOA |
ras homolog family member A |
387 |
P61586 |
chr3: 49,359,145-49,412,998 |
STMN1 |
stathmin 1 |
3925 |
P16949 |
chr1: 25,884,181-25,906,991 |
MIR155 |
microRNA 155 |
406947 |
N/A |
chr21: 25,573,980-25,574,044 |
MIR21 |
microRNA 21 |
406991 |
N/A |
chr17: 59,841,266-59,841,337 |
MIR25 |
microRNA 25 |
407014 |
N/A |
chr7: 100,093,560-100,093,643 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
4082 |
P29966 |
chr6: 113,857,362-113,863,471 |
MCL1 |
myeloid cell leukemia 1 |
4170 |
Q07820 |
chr1: 150,574,551-150,579,738 |
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase |
4193 |
Q00987 |
chr12: 68,808,176-68,850,686 |
MDM4 |
MDM4, p53 regulator |
4194 |
O15151 |
chr1: 204,516,379-204,558,120 |
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
MMP9 |
matrix metallopeptidase 9 |
4318 |
P14780 |
chr20: 46,008,908-46,016,561 |
MMP16 |
matrix metallopeptidase 16 |
4325 |
P51512 |
chr8: 88,032,009-88,328,025 |
ABCC1 |
ATP binding cassette subfamily C member 1 |
4363 |
P33527 |
chr16: 15,949,577-16,143,074 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
4609 |
P01106 |
chr8: 127,735,434-127,741,434 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 |
P19838 |
chr4: 102,501,329-102,617,302 |
NOTCH1 |
notch 1 |
4851 |
P46531 |
chr9: 136,494,444-136,545,862 |
NOTCH2 |
notch 2 |
4853 |
Q04721 |
chr1: 119,911,553-120,069,626 |
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 |
P01111 |
chr1: 114,704,469-114,716,894 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
SERPINB5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
5268 |
P36952 |
chr18: 63,476,761-63,505,085 |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
PLAU |
plasminogen activator, urokinase |
5328 |
P00749 |
chr10: 73,909,177-73,917,497 |
PLCG2 |
phospholipase C gamma 2 |
5336 |
P16885 |
chr16: 81,739,097-81,962,693 |
DDIT4 |
DNA damage inducible transcript 4 |
54541 |
Q9NX09 |
chr10: 72,273,920-72,276,036 |
PRKCA |
protein kinase C, alpha |
5578 |
P17252 |
chr17: 66,302,636-66,810,743 |
PRKCB |
protein kinase C, beta |
5579 |
P05771 |
chr16: 23,836,001-24,220,611 |
MAPK1 |
mitogen-activated protein kinase 1 |
5594 |
P28482 |
chr22: 21,754,500-21,867,680 |
MAPK7 |
mitogen-activated protein kinase 7 |
5598 |
Q13164 |
chr17: 19,377,721-19,383,544 |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
5604 |
Q02750 |
chr15: 66,386,817-66,492,312 |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
5605 |
P36507 |
chr19: 4,090,321-4,124,129 |
PTEN |
phosphatase and tensin homolog |
5728 |
P60484 |
chr10: 87,863,113-87,971,930 |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
5743 |
P35354 |
chr1: 186,671,791-186,680,427 |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
5894 |
P04049 |
chr3: 12,583,601-12,664,226 |
BCL2 |
B-cell CLL/lymphoma 2 |
596 |
P10415 |
chr18: 63,123,346-63,320,128 |
RDX |
radixin |
5962 |
P35241 |
chr11: 110,174,880-110,296,722 |
BCL2L2 |
BCL2L2-PABPN1 readthrough |
599 |
Q92843 |
chr14: 23,298,790-23,311,759 |
BMPR2 |
bone morphogenetic protein receptor type II |
659 |
Q13873 |
chr2: 202,376,936-202,567,751 |
FSCN1 |
fascin actin-bundling protein 1 |
6624 |
Q16658 |
chr7: 5,592,823-5,606,655 |
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 |
Q07889 |
chr2: 38,981,396-39,124,345 |
SOS2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
6655 |
Q07890 |
chr14: 50,117,120-50,231,558 |
SOX4 |
SRY-box 4 |
6659 |
Q06945 |
chr6: 21,592,768-21,598,619 |
BRCA1 |
breast cancer 1 |
672 |
P38398 |
chr17: 43,044,295-43,170,245 |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 |
P40763 |
chr17: 42,313,324-42,388,568 |
ZEB1 |
zinc finger E-box binding homeobox 1 |
6935 |
P37275 |
chr10: 31,318,495-31,529,814 |
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
THBS1 |
thrombospondin 1 |
7057 |
P07996 |
chr15: 39,581,079-39,599,466 |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
7078 |
P35625 |
chr22: 32,801,701-32,863,043 |
TNR |
tenascin R |
7143 |
Q92752 |
chr1: 175,315,194-175,743,770 |
TNXB |
tenascin XB |
7148 |
P22105 |
chr6: 32,041,154-32,115,334 |
TP53 |
tumor protein p53 |
7157 |
P04637 |
chr17: 7,661,779-7,687,550 |
TPM1 |
tropomyosin 1 (alpha) |
7168 |
P09493 |
chr15: 63,042,632-63,071,915 |
UBE2I |
ubiquitin conjugating enzyme E2I |
7329 |
P63279 |
chr16: 1,308,880-1,327,018 |
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
EZR |
ezrin |
7430 |
P15311 |
chr6: 158,765,741-158,819,412 |
VIM |
vimentin |
7431 |
P08670 |
chr10: 17,228,259-17,237,593 |
WNT3 |
wingless-type MMTV integration site family member 3 |
7473 |
P56703 |
chr17: 46,762,506-46,833,154 |
HMGA2 |
high mobility group AT-hook 2 |
8091 |
P52926 |
chr12: 65,824,131-65,966,295 |
RECK |
reversion-inducing-cysteine-rich protein with kazal motifs |
8434 |
O95980 |
chr9: 36,036,433-36,124,451 |
SOCS1 |
suppressor of cytokine signaling 1 |
8651 |
O15524 |
chr16: 11,254,405-11,256,179 |
IRS2 |
insulin receptor substrate 2 |
8660 |
Q9Y4H2 |
chr13: 109,752,698-109,786,568 |
CCND2 |
cyclin D2 |
894 |
P30279 |
chr12: 4,273,772-4,305,350 |
CCNG1 |
cyclin G1 |
900 |
P51959 |
chr5: 163,437,569-163,446,151 |
CCNE2 |
cyclin E2 |
9134 |
O96020 |
chr8: 94,879,770-94,896,678 |
RPS6KA5 |
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
9252 |
O75582 |
chr14: 90,847,862-91,060,636 |
KIF23 |
kinesin family member 23 |
9493 |
Q02241 |
chr15: 69,414,246-69,448,427 |
CD44 |
CD44 molecule (Indian blood group) |
960 |
P16070 |
chr11: 35,138,870-35,232,402 |
HDAC4 |
histone deacetylase 4 |
9759 |
P56524 |
chr2: 239,048,168-239,401,654 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
9839 |
O60315 |
chr2: 144,364,364-144,524,583 |
CDC25A |
cell division cycle 25A |
993 |
P30304 |
chr3: 48,157,146-48,188,402 |
CDC25B |
cell division cycle 25B |
994 |
P30305 |
chr20: 3,786,772-3,806,121 |
CDC25C |
cell division cycle 25C |
995 |
P30307 |
chr5: 138,285,265-138,338,355 |